Digirad Corp.
Thoratec kills it in Q1, Wall Street shrugs | Earnings Roundup
Thoratec (NSDQ:THOR) started today up 7.2% as investors reacted to its stellar 1st-quarter numbers, but by the time the market closed THOR shares had fallen back to Earth to close at $34.46, down 0.1%.
The heart pump maker posted profits of $25.5 million, or 43¢ per diluted share, on sales of $126.8 million for the 3 months ended March 31.
Amgen mourns death of founder George Rathmann | Personnel Moves
Incoming BSX CEO Mahoney’s 2011 total tops $11.5M | Personnel Moves
NuVasive swings to Q4, 2011 red | Earnings Roundup
NuVasive (NSDQ:NUVA) swung to red for the 4th quarter and full-year 2011, largely on the back of an $18.2 million writedown of intangible assets.
The San Diego-based spinal implant maker posted a loss of $10.0 million, or 24 cents per share, on sales of $150.2 million for the 3 months ended Dec. 31, 2012. That’s a top-line gain of 16.2% compared with Q4 2010, when NuVasive posted profits of $61.9 million, or $1.39 EPS.
Boston Scientific lauds NICE results from the U.K. | Regulatory Roundup
Boston Scientific Corp. (NYSE:BSX) lauded a new guidance released by the research arm of the U.K.’s National Health Service, the country’s publicly funded health care system.
The National Institute for Health & Clinical Excellence issued a final guidance for bronchial thermoplasty as an option for patients with severe asthma that isn’t controllable with drugs, a boon for Boston Scientific’s Alair.
Smith & Nephew falls on softer orthopedic margins | Earnings Roundup
Lower margins for Smith & Nephew’s (NYSE:SNN) bread-and-butter orthopedics division drove the British company’s third-quarter profits down nearly 3 percent for the three months ended Oct. 1.
Smith & Nephew posted profits of $133 million, or 14.9 cents per share, on sales of $1.03 billion for the quarter – a top-line increase of 9.7 percent when compared with the $941 million in revenues reported for the same period last year. But Q3 2010 profits were $137 million, or 15.4 cents per share.
Former CMS CMO Straube joins NxStage board | Personnel Moves
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
MedGadget’s MedTech Monday: Boston Scientific’s Kinetix guidewire
Boston Scientific’s Kinetix guidewire promises more torque control: Boston Scientific Corp. (NYSE:BSX) announced new nitinol-based technology for guidewires, the small flexible wires used for control in percutaneous procedures. The Natick, Mass.-based medical device giant claims its new Kinetix guidewire boasts improved torque control and flexibility for getting around those tight corners in the left anterior descending artery. The improvements come from controlled flexibility in the sleeve itself, rather than from the center wire as with traditional spring coil design.